Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Thorough evaluation and surgery are crucial for managing rare ovarian tumors in postmenopausal women with high androgen levels.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Cosmetic treatments can replenish key amino acids in damaged hair, improving its strength and appearance.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

In the Middle Ages, European noblewomen intentionally removed forehead hair to be fashionable, showing how beauty standards can affect the perception of hair loss.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Leydig cell hyperplasia can cause virilization in postmenopausal women and is treatable with surgery.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Frontal Fibrosing Alopecia may be a complex condition linked to hormonal changes in women, not just a form of Lichen Planopilaris.

Thorough evaluation is crucial for postmenopausal women with virilization to detect rare ovarian tumors.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

Benign conditions can mimic serious ones in postmenopausal hyperandrogenism, requiring careful diagnosis.

Postmenopausal women with unusual hair growth should be checked for ovarian tumors.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

Bilateral salpingo-oophorectomy resolved hyperandrogenism in a postmenopausal woman with rare ovarian tumors.

A rare ovarian tumor caused high testosterone in a postmenopausal woman, resolved by surgery.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.